FDA backs food safety research
This article was originally published in The Tan Sheet
Executive Summary
FDA intends to fund the Western Center for Food Safety for up to five years and with up to $4.1 million, according to a notice prepared for the June 30 Federal Register. FDA's support of the collaborative center, to be located at the University of California, Davis, "will improve public health by creating an applied research, education, and outreach program" that considers interactions between food protection and agriculture, the notice says. WCFS programs will include contributions from industry, academia, non-governmental organizations and international entities to develop best practices for mitigating risks during agricultural production. FDA has offered funding to state food protection task forces and sought cooperation with state agencies to root out contaminants in the food production cycle (1"The Tan Sheet" June 16, 2008, In Brief)...
You may also be interested in...
Food safety grant program
Conference grant funding is available for meetings of State Food Protection Task Forces, FDA announces in a June 10 Federal Register notice that highlights the name change of the grant program, formerly called the State Food Safety Task Force. The change is intended to align the program with the FDA Food Protection Plan and new policies that apply to the conference grant program, the agency says. The notice is also intended to encourage the development of a task force within each state and provide funding for meetings, according to FDA. The agency plans to provide approximately $160,000 in direct costs in support of the program in fiscal 2008, with 32 awards allotted for up to $5,000 per award. Additionally, FDA plans to work with state agencies to improve the agency's capability to link possible contaminants to specific foods and identify where in the production cycle food products become contaminated...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.